Cardiovascular diseases are responsible for one-third of all deaths in the world. Several factors contribute to the current trend including micronutrient vitamin deficiencies (MVDs), however, opinions regarding the role of MVDs in CVDs are inconsistent; this could impact on micronutrient vitamins intake. The aim of this review was to provide a brief overview of published evidence on the associations between MVDs and CVDs, assess the interactions between micronutrients and cardiovascular endpoints, and identify current related research needs. Literature search conducted on studies published between 1963 and 2016 indicates that MVDs are common and are related to adverse cardiovascular endpoints through various mechanisms, including impaired antioxidant and immune response mechanisms; and anti-inflammatory activities. Some micronutrients directly impact on CVDs; others act as critical cofactors in several biochemical processes. Several methodologic flaws, environmental and individual susceptibility factors, lack of determination of baseline serum levels of complementary micronutrients, absence of uniformly accepted cut-off values, and interactions between micronutrients may partly account for discordant results across studies. Although MVD is a significant risk factor for CVDs, supplementation with single or paired micronutrients for primary prevention of CVDs in healthy adults with no special nutritional needs is discouraged; there is insufficient evidence to determine the benefit/harm of such supplementation.
| Published in | European Journal of Preventive Medicine (Volume 5, Issue 1) |
| DOI | 10.11648/j.ejpm.20170501.11 |
| Page(s) | 1-18 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
β-Carotene, Ascorbic Acid, Folate, Calciferol, Tocopherol, Deficiency, Heart Disease
| [1] | Voutilainen S, Nurmi T, Mursu J, Rissanen TH. Carotenoids and Cardiovascular health. Am J Clin Nutr 2006; 83 (6): 1265-71. |
| [2] | Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3 (11): e442. |
| [3] | Liu M, Li C, Sun R, Zeng Y, Chen S, Zhang P. Vitamin D nutritional status and the risk for cardiovascular disease (Review). Expt Ther Med 2016; 11 (4): 1189-93. |
| [4] | Vijayaraghavan K. Treatment of dyslipidemia in patients with type-2 dubieties. Lipids in health and disease 2010, 9: 144. Doi.101186/1476: 511X-9-144. |
| [5] | Gayathri K, Jayachandran KS, Vasanthi HR, Rajamanickam GV. Cardio-protective effect of lemongrass as evidenced by biochemical and histopathological changes in experimentally induced cardiotoxicity. Human and experimental toxicology 2011: 30 (8): 1073-82. |
| [6] | Guallar E, Jiménez FJ, Van ’t Veer P, Bode P, Riemersma RA, Gόmez-Aracena J et al. Low toenail chromium concentration and increased risk of nonfatal myocardiac infarction. Am J Epidemiol 2005; 162 (2): 157-64. |
| [7] | Barker DP. In utero programming of chronic disease. Clinical Science 1998a; 95: 115-128. |
| [8] | Barker DP. Mothers, babies and health in later life. 2nd ed. Edinburgh: Churchill Livingstone 1998b. |
| [9] | Ravelli AC, an der Meulan JH, Michels RP, Osmond C, Barker DJ, Hales CN. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998; 350: 173-77. |
| [10] | Rosario JF, Gomez MP, Anbu P. Does the maternal micronutrient deficiency (copper or zinc or vitamin E) modulate the expression of placenta 11β hydroxysteroid dehydrogenase -2 per se predispose offspring to insulin resistance and hypertension in later life? Indian J Physiol Pharmacol 2008; 52: 355-65. |
| [11] | Stewart CP, Christian P, Schulze KJ, Leclerq SC, West KPJr, Khatry SK. Antenatal micronutrient supplementation reduces metabolic syndrome in 6- to 8- year-old children in rural. Nepal J Nutr 2009; 139: 1575-81. |
| [12] | Christian P, Stewart CP. Maternal micronutrient deficiency, fetal development and the risk of chronic disease. J Nutr 2010; 140: 437-45. |
| [13] | Prohaska JR, Copper. In: Erdman JW, Macdonald IA, Zeisel SH. Eds. Present knowledge in Nutrition 10th Ed. Anies: Wiley-Blackwell, 2012: 540-53. |
| [14] | Gaziano JM. Vitamin E and cardiovascular disease: observational studies. Ann N Y Acad Sci 2004; 1031: 280-91. |
| [15] | Toole TF, Mahnow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al. Lowering homocysteine in patients with ischemic strole to prevent recurrent stroke, myocardial infarction and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled-trial. JAMA 2004; 291: 565-75. |
| [16] | Spence JD, Bang H, Chambles LE, Stampfer MJ. Vitamin Intervention for Stroke Prevention trial: an efficacy analysis. Stroke 2005; 36 (11): 2404-9. |
| [17] | Spence JD. Homocysteine: call off the funeral. Stroke 2006; 37 (2): 282-3. |
| [18] | Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willet WC, et al. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healty men. Diabetes care 2004: 27 (9): 2211-6. |
| [19] | Bonaa KH, Njolstad I, Ueland PM, Schirmer H et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354 (15): 1578-88. |
| [20] | Leone N, Courbon D, Ducimetiere P, Zureik M. Zinc, copper and magnesium and risks for all cause, cancer, and cardiovascular mortality. Epidemiology 2006; 17 (3): 308-14. |
| [21] | Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008; 300 (7): 795-804. |
| [22] | Henderson L, Irving K, Gregory JF, Bates CJ, Pentice A, Perks J, Swan G, Farron M. The National Diet and Nutrition Survey: Adults Aged 19 to 64 years. Vol 3: vitamin and mineral intake and urinary analyst. 2003; vol. 3: ISBN: 0116215682 London: The stationary office. |
| [23] | Van Rossum CT, Fransen HP, Verkaik-Kloosterman J, Buurma-Rethans EJ, Ocke MC. Dutch National Food Consumption survey 2009-2010: Diet of Children and Adults Aged 7 to 69 years. 2011; Bilthoven: RIVM. Report no. 350050006/2011. Bilthoven; National Institute for Public Health and the Environment. |
| [24] | Ecker O, Weinberger K, Qaim M. Patterns and determinants of dietary micronutrient deficiencies in rural areas of East Africa. Afecan Journal of Agricultural and Resource Economic 2010: 4 (2); 175-94. |
| [25] | Schroeder HA, Nason AP, Tipton IH. Chromium deficiency as a factor in atherosclerosis. J. Chronic Dis 1970; 23 (2): 123-42. |
| [26] | Althuis MD, Jorden NE, Ludington EA, Wiltes JT. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr 2002; 76: 148-55. |
| [27] | Newman HA, Lelghton RF, Lanese RR, Freedland NA. Serum chromium and angiographically determined coronary artery disease. Clin Chem 1978; 24 (4): 541-44. |
| [28] | Simonoff M, Llabador Y, Hamon C, Peers AM, Simonoff GN. Low plasma chromium in patients with coronary artery and heart disease. Biol Trace Elem Res 1984; 6 (5): 431-39. |
| [29] | Swecker BJ, Chromium. In: Shils ME, Olson JA, Shike M et al, eds. Modern nutrition in health and disease. Baltimore, MD: Williams and Wilkins company, 1999: 277-82. |
| [30] | Panel on Micronutrients, Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin A, Vitamin K, arsenic, boron, chromium, copper, iodine, iron manganese, molybdenum, nickel, silicon, vanadium, and zinc Washington, DC: National Academy Press, 2001. |
| [31] | Houston MC. The role of nutrition and nutraceutical supplements in the treatment of hypertension. World J Cardiol 2014: 6 (2) 38-66. |
| [32] | Tribble DL. Antioxidant consumption and risk coronary heart disease. Emphasis on vitamin C, vitamin E, and β-carotene. A statement for health professionals from the Am Heart Assoc Circ 1999; 99: 591-95. |
| [33] | Soydinc S, Celik A, Demiryurek S, Davutoglu V, Taracioglu M, Aksoy M. The relationship between oxidative stress, nitric oxide and coronary artery disease. Eur J Gen Med 2007; 4 (2): 62-6. |
| [34] | Wattanapitayakul SK, Bauer JA. Oxidative pathways in cardiovascular disease. Roles, mechanisms, and therapeutic implications. Pharmacol Ther 2001: 89: 187-206. |
| [35] | Fortmann SP, Burda BU, Senger CA, Lin SJ, Whitlock EP. Vitamin and Mineral supplements in the primary prevention of cardiovascular diseases and cancer: An updated systematic evidence review for the U.S preventive services task force. Ann Intern Med 2013; 159 (12): 824-34. |
| [36] | Gorski PA, Ceholski DK, Hajjar RJ. Altered myocardial calcium cycling and energetic in heart failure-a rational approach for disease treatment. Cell Metab 2015: 21 (2): 183-94. |
| [37] | Khan AM, Sullivan L, McCabe E, Levy D, Vasan RS, Wang TJ. Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease. am Heart J 2010; 160 (4): 715-20. |
| [38] | Slow RC, Richards JP, Pedley KC, Leeke DS and Mann GE. Vitamin C proteins human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler Thromb Vasc Biol 1999; 19: 2387-94. |
| [39] | Ludwig DS. The glycemic index: physiological mechanisms relating obesity, diabetes and cardiovascular disease. J Am Med Assoc 2002; 287: 2414-23. |
| [40] | Wolever TM, Jenkins DJ. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr 1986; 43: 167-72. |
| [41] | Beck-Nielsen H. Insulin resistance: organ manifestation and cellular mechanism. Ugeskr Laeger 2002; 164: 2130-35. |
| [42] | Reaven GM. Insulin resistance and its consequences. In: Le Roith D, Taylor SI, Olefasky JM, eds. Diabetes mellitus: a fundamental and clinical text. 3rd ed. Philadelphia: Lippincott, Williams and Wilkins 2004; 899-915. |
| [43] | Chiplonkar SA, Agte VV, Tarwadi KV, Paknikar KM, Diwate UP. Micronutrient deficiencies as predisposing factors for hypertension in lacto-vegetarian Indian adults. J Am Coll Nutr. 2004: 23 (3); 239–47. |
| [44] | Houston MC. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular diseases. Ther Advan Cardiovasc Dis 2010: 4 (3); 165-83. |
| [45] | Patrick L. βeta-carotene: the controversy continues. Altern Med 2000; 5 (6): 350-545. |
| [46] | Tulchinsky TH. Micronutrient deficiency condition: Global Health Issues. Pub Health Rev 2010, 32 (1), 243-55. |
| [47] | Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson JE, Willet WC. Dietary carotenoids and risk of coronary disease in women. Am J Clin Nutr 2003; 77: 1390-9. |
| [48] | Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA 1994; 272 (18): 1439–41. |
| [49] | Gaziano JM, Manson JE, Branch LG, Colditz GA, Willet WC, Buring JE. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly, Ann Epidemiol 1995; 5 (4): 255-60. |
| [50] | Tavani A, Negri E, D’Avanzo B, La Vecchia C. Beta-carotene intake and risk of nonfatal acute myocardial infarction in women. Eur J Epidemiol 1997; 13 (6): 631–37. |
| [51] | Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al., Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-49. |
| [52] | Hak AE, Stampfer MJ, Campos H, Sesso HD, Gaziano MJ, Willet W, et al. Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation 2003; 108: 802–7. |
| [53] | Omen GS, Goodman GE. Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334 (18); 1150-55. |
| [54] | Csepanyi E, Czompa A, Haines D, Lekli I, Bakondi E, Balla G, et al. Cardiovascular effects of low versus high-dose beta-carotene in a rat model. Pharmacol Res 2015: 100; 148-56. |
| [55] | Street DA, Comstuck GW, Salkeld RM, Schuep W, Klag MJ. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 1994; 90: 1154-61. |
| [56] | Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, et al. Oxygenated carotenoids lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study. Circulation 2001; 103 (24): 2922-27. |
| [57] | Dixon ZR, Burn BJ, Clifford A, Frankel EN, Schneeman BO, Parks E, et al. Effects of a carotene deficient diet on measures of oxidative susceptibility and superoxide dismutase activity in adult women. Free Radic Biol Med 1994: 17 (6): 537-44. |
| [58] | Gottlieb K, Zarling EJ, Mobarhan S, Bowen P. Sugerman S. Beta carotene decreases markers of lipid peroxidation in healthy volunteers. Nutr. Cancer 1993; 19 (2): 207-12. |
| [59] | Moyer VA. Vitamin, Mineral, and multi-vitamin supplements for the primary prevention of cardiovascular disease and cancer. U.S. Preventive services task force recommendation statement. Ann Intern Med 2014: 60 (8): 558-64. |
| [60] | Stahl W, Sies H, Physical quenching of singlet oxygen and cis-trans isomerization of carotenoids. Ann N Y Acad Sci 1993; 691: 10-9. |
| [61] | Mottaghi A, Salehi G, Keshvarz A, Sezavar H, Saboor-Yaraghi A-A. The influence of vitamin A supplementation on FOXP3 and TGF-Gene Expression in Atheroscleratic Patients. J. Nutrigenet Nutrigenomics 2012; 5: 314-26. |
| [62] | Zeba AN, Delisle HF, Rossier C, Renier G. Association of high-sensitivity C-reactive protein with cardiometabolic risk factors and micronutrient deficiencies in adults of Ouagadougou, Burkina Faso. Br J Nutr 2012; 109 (7): 1266-75. |
| [63] | Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347 (20): 1557-65. |
| [64] | Leslie AG. Integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr 2006; 62 (pt1): 48-57. |
| [65] | Nijmeijer R, Lagrand WK, Lubbers YTP, Visser CA, Meijer CJL, Niessen HW, Hack CE. C-reactive protein activated complement in infracted human myocardium. American J. of Pathology 2003: 163 (1): 269-75. |
| [66] | Kang SG, Lim HW, Andrisani OM, Broxmeyer HE, Kim CH. Vitamin A metabolites induce gut-homing FOXP3+ regulatory T-cells. J Immunol 2007; 179 (6): 3724-33. |
| [67] | Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, Shevach LM, O’ Shea JJ: Retinoic acid inhibits Th 17 polarization and enhances FOXP3 expression through a stat-3/stat-5 independent signaling pathway. Blood 2008; 111 (3): 1013-28. |
| [68] | Schambach F, Schupp M, Lazar MA, Reiner SL. Activation of retinoic acid receptor-alpha favors regulatory T-cell induction at the expense of IL-17-Secerting T-helper cell differentiation. Eur J Immunol 2007; 37 (9): 2396-99. |
| [69] | Ntaios G, Savopoulos C, Grekas D, Hatzitolios. The controversial role of B-vitamins in cardiovascular risk: an update. Archives of cardiovascular disease 2009; 102, 847-54. |
| [70] | Carmel R, Jacobsen DW, editors. Homocysteine in Health and Disease. Cambridge UK: Cambridge University Press 2001. |
| [71] | Nygârg O, Vollset SE, Refsum H et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 1995: 274; 1526-33. |
| [72] | Chen K-J, Pan W-H, Yang F-L, Wei I-L, Shaw N-S, Lin B-F. association of B vitamins status and homocysteine levels in elderly Taiwanese. Asia Pac J Clin Nutr 2005; 53 (6): 731-39. |
| [73] | Harker LA, Harlan JM, Ross R. Effect of sulfinpyrazone on homocysteine induced endothelial injury and arteriosclerosis in baboons. Circ Res 1983; 53 (6): 731-39. |
| [74] | Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N. Engl J. Med 1998; 338: 1042-50. |
| [75] | Harker LA, Slichter SJ, Scott CR, Ross R. Homocysteinemia: Vascular injury and arterial thrombosis. N Engl J Med 1974; 291: 537-43. |
| [76] | Abraham JM, Cho L. The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Cleve. Clin J Med 2010: 77 (12); 911-18. |
| [77] | Yap S, Boers GH, Wilcken B, Wikken DE, Breton DP, Lee PJ, et al., Vascular outcome in patients with homocysteinuria due to cystathione beta-synthase deficiency treated chronically; a multi-center observational study. Arteriosler. Thromb Vasc Biol 2001; 21 (12): 2080-85. |
| [78] | Schnyder G. Roffi M. Flammer Y, Pin R, Hess OM. Effect of homocyusteine lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcomes after percutaneous coronary intervention: the swiss heart study: a randomized controlled trail. JAMA 2002: 288: 973-70. |
| [79] | Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease evidence on causality from a meta-analysis. British Medical Journal 2002: 325: 1202-8. |
| [80] | Lindgren A, Brattstrom L, Norving B, et al. Plasma homocysteine in the acute and convalescent phase after stroke. Stroke 1995; 26: 795-800. |
| [81] | Cheng SW, Ting AC, Wong J. Fasting total plasma homocysteine and atherosclerotic peripherail vascular diseases. Ann Vasc Surg 1997: 11 (3): 217-23. |
| [82] | den Heijer M, Koster T, Bloin HJ, Bos GMJ, Briet E, Reitsma PH, et al., Hyperhomocysteinemia as a risk factor for deep-vein thrombosis N Engl J Med 1996: 334; 759-62. |
| [83] | Molgaard J, Malinow MR, Lassvik C, Holm AC, Upson B, Olsson AG. Hyperhomocysteinaemia: an independent risk factor for intermittent claudication. J Inter Med 1992: 231 (3); 273-9. |
| [84] | Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE, et al. Plasma homocysteine levels and mortality in patients with coronary artery diseases. N Engl J Med 1997; 337: 230-6. |
| [85] | Adekunle AS and Adedeji AL. Anti-atherogenic effect of supplementation with vitamin B6 (Pyridoxine) in albino rats. African Journal of Biochemistry Research 2011; 5 (13): 352-5. |
| [86] | Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Mason JE, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998: 279: 359-64. |
| [87] | Merchant AT, Hu FB, Spiegelman D, Willett WC, Rimm EB, Ascherio A. The use of B vitamin supplements and peripheral arterial disease risk in men are inversely related. J. Nutr. 2003; 133 (9): 2863-67. |
| [88] | Cui R, Iso H, Date C, Kikuchi S Tamakoshi A. Japan collaborative cohort study group. Dietary folate and vitamin B6 and B12 intake in relation to mortality from cardiovascular disease: Japan Collaborative cohort study. Stroke 2010; 41 (6): 1285-89. |
| [89] | Mosca L. Novel cardiovascular risk factors: do they add value to your practice? Am Fam Physician 2003; 67: 264-66. |
| [90] | Anderson RA. Natritional factors influencing the glucose/insulin system: chromium. J Am Coll Nutr 1997; 16 (5): 404-10. |
| [91] | Lonn E. Homocysteine-lowering B vitamin therapy in cardiovascular prevention-wrong again? JAMA 2008; 299: 2086-87 |
| [92] | Milani RV, Lavie CJ. Homocysteine: the Rubik’s cube of cardiovascular risk factor. Mayo Clin Proc 2008; 83: 1200-2. |
| [93] | Bazzano LA. Folic acid supplementation and cardiovascular disease: the state of the art. Am J Med Sci 2009; 338: 48-9. |
| [94] | Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyyen J, Danielson E, et al., Effect of folic acid and B-vitamins on risks of cardiovascular events and total mortality among women of high risk of cardiovascular disease: a randomized trail. JAMA 2008; 299: 2027-36. |
| [95] | SEARCH collaborative Group: Armitage IM, Bowman I, Clarke RI et al. Effects of homocysteine lowering eith folic acid plus vitamin B12 Vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trail JAMA 2010: 303 (24); 2486-94. |
| [96] | Omid T-S, Heiko K, Alexandra W, Heike S, Natalia U, Ulrich H, et al. The Cardiac effects of prolonged vitamin B12 and Folate deficiency in rats. Cardiovasc Toxicol 2009; 9 (2): 95-102. |
| [97] | Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345 (22): 1583-92. |
| [98] | UNICEF and Micronutrient Initiative. Vitamin and mineral deficiencies: a global progress report. Ottawa (Canada): The Micronutrient Initiative 2004. |
| [99] | Das S, Periyasamy R, Pandey KN,. Activation of IKK/NF-kappa beta provokes renal inflammatory responses in guanylyl cyclase 1 natriuretic peptide receptor- A gene-knockout mice. Physiol Genomics 2012; 44: 430-42. |
| [100] | Brouwer IA, van Dusseldorp M, Thomas CM, Duran M, Hautvast JG, et al. Low dose folic acid supplementation decrease plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr 1999: 69; 99-104. |
| [101] | Ridker PM, Manson JE, Buring JE Shih J, Matias M, Hennekens CH. Homo cysteine and risk of cardiovascular diseases among post menopause women. JAMA 1999, 281: 1817-21. |
| [102] | Ueland PM et al. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000; 72: 324-32. |
| [103] | Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E. Increased risk of cardiovascular diseases at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993; 57 (suppl 5): 787S-97S. |
| [104] | Riemersma RA, Carruthers KF, Elton RA, Fox KAA. Vitamin C and the risk of acute myocardial infarction1-3. Am J Clin Nutr 2000; 71: 1181-6. |
| [105] | Tunstall-Pedoe H, Woodward M, Tavendale R, Brook RA, McClusky MK. Comparison of the prediction by 27 different factors of cocronary heart disease and death in men and women of the Scottish Heart Study: cohort study. BMJ 1997; 315: 722-9. |
| [106] | Vita JA, Keaney JF, Raby KE, Morow JD, Freedman JE, Lynch S, et al. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. J Am Coll Cardiol 1998; 31: 980-6. |
| [107] | Myung SK, Ju W, Cho B, Oh SW, Park SM, Koo BK, et al. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic reviewed meta-analysis of randomized controlled trials. BMJ 2013; 346: f10. |
| [108] | Konx EG. Ischemic heart disease mortality and dietary intake of calcium. Lancet 1973; 1: 1465-7. |
| [109] | Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality amonga sample of the United State Population. Epidemiology 1992; 3: 194-202. |
| [110] | Rimm EB, Stampfer MJ, Ascherio A, et al.: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993, 328: 1450–56. |
| [111] | Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J. Dietary vitamin C and Bbeta carotene and risk of death in middle-aged men. The Western Electric Study. Am J Epidemiol 1995; 142: 1269-78. |
| [112] | Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from strioke and coronary heart disease in a cohort of elderly people. BMJ 1995; 310: 1563-6. |
| [113] | Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999; 69: 1086-107. |
| [114] | NyyssÖnen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: prospective study of men from Eastern Finland. BMJ 1997; 314: 634-8. |
| [115] | Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC Norfolk prospective study: a prospective population study. Lancet 2001; 357: 657-63. |
| [116] | Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, et al. Effects of hormonal replacement therapy and antioxidant vitamin supplements on coronary artherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 2002; 288: 2432-40. |
| [117] | Shenkin A. Micronutrients deficicency conditions: global health issues. Pub H Rev 2010; 32: 243-55. |
| [118] | Jaxa-Chamiec T, Bednarz B, Drozdowska D, Gessek J, Gniot J, Janik K, et al. Antioxidant effects of combined vitamin S and E in acute myocardial infarction. The randomized, double blind, placebo controlled, multicenter pilot, Myocardial infarction and vitamins (MIVIT) trial. Kardiol. Pol 2005; 62 (4): 344-50. |
| [119] | Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc. Soc. Exp Biol. Med 1999; 222 (3): 196-204. |
| [120] | Huang A, Vita JA, Venema RC, Keaney JF. Ascorbic acid enhances endothelial nitricoxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 2000; 275 (23): 17399-406. |
| [121] | Mozos I and Marginean O. Links between vitamin D deficiency and cardiovascular disease. BioMed Res Int 2015 (2015); 1099275: 12. http: //dx.doi.org/10.1155/2015/2015/109275. |
| [122] | Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J. Clin. Nutr 2004; 80 (6): 1678s-88s. |
| [123] | Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxy vitamin D and risk of myocardial infarction in men: a prospective study. Arch Inter Med 2008; 168 (11): 1174-80. |
| [124] | Atabek ME, Eklioglu BS, Akyurek N and Alp H. Association between vitamin D level and cardiovascular risk in obese children and adolescents. J. Pedeiatr Endocrinol Metab 2014; 27 (7-8): 661-6. |
| [125] | Holick MF, Binkley NC, Bischoff-ferrari HA, Gordon CM, Hanley DA, Heaney RP et al., Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96 (7): 1911-30. |
| [126] | Muscogiuri G, Sorice GP, Ajjan R, Mezza T, Pilz S, Prioletta A, Scragg R, Volpe SL, Witham MD, Giaccari A. Can vitamin D deficiency cause diabetes and cardiovascular disease? Present evidence and future perspectives. Nutr. Metab Cardiovasc Dis 2012; 22 (2): 81-7. |
| [127] | Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleiter-Pammer A, Dimai HP, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008: 93: 3927-35. |
| [128] | Marniemi J, Alanen E, Impivaara O, Seppanen R, Hakala P, Rajala T, et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 2005; 15: 188-97. |
| [129] | Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, et al. cardiac hypertrophy in vitamin D receptor knock out mice: role of the systemic and cardiac rennin—angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288: E125-E132. |
| [130] | Kendrick J, Targher G, Smits G, and Chonchol M. 25-Hydroxy vitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis 2009; 205 (1): 255-60. |
| [131] | Bolland MJ, Bacon CJ, Home AM, Mason BH, Ames RW, Wang TK, et al. Vitamin D insufficiency and health outcomes over 5-1 in older women. AM J Clin Nutr 2010; 91 (1): 82-89. |
| [132] | Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson HC, Manson JE, Sidney S, Trevisan M; Women’s Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007: 115 (7); 846-54. |
| [133] | Trivedic DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferal) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ 2003; 326 (7387): 469. |
| [134] | Michos ED, Blumenthal RS. Vitamin D supplementation and cardiovascular disease risk. Circulation 2007; 115: 827-8. |
| [135] | Zittermann A, Dembinski J, Stehle P. Low vitamin D status is associated with lo cord blood levels of the immune suppressive cytokine interleukin-10. Pediatr Allergy Immunol 2004; 15 (3): 242-6. |
| [136] | Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sc. 2009: 338 (1), 40-4. |
| [137] | Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007; 85 (3): 649-50. |
| [138] | Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87 (4): 1080S-6S. |
| [139] | Vieth R. Vitamin D supplementation 25-hydroxy vitamin D concentrations and safety. Am J Clin Nutr 1999; 69 (5): 842-56. |
| [140] | Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. AM J Clin Nutr 2000; 72 (3): 690-3. |
| [141] | Hirani V, Tull K, Ali A, Mindell J. Urgent action needed to improve vitamin D status among older people in England: Age Aging 2010; 39 (4): 62-8. |
| [142] | Schlaifer JD, Mancini GB, O’Neill BJ, Pitt B, Haber HE, Pepine CJ. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND investigators. Trial on Reversing Endothelial Dysfunction. Cradiovasc Drugs Ther 1999: 13; 201-9. |
| [143] | Lausen JB, Rajagopalan S, Galis Z, Terpey M, Freeman BA, Harrison DG. Role of superoxide in angiotension ll-induced but not catecholamine-induced hypertension. Circulation 1997; 95: 588-93. |
| [144] | Teng M, Wolf M, Ofsthun MN, Lazarus JM, Herman MA, Camargo CA, Thadhani R. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16 (4): 1115-25. |
| [145] | Feki M, Souissi M, Mokhtar E, Hsairi M, Kaabachi N, Antebi H, Alcindor LG, Mechmeche R, Mebazaa A. Vitamin E and Coronary Heart Disease in Tunisians. Clin Chem 2000; 46 (9): 1401-5. |
| [146] | Sklowdska M, Wasovicz W, Gromadzinska J, Miroslaw W, Strzelczy KM, Malzuk J et al. Selenium and vitamin E concentration in plasma and erythrocytes of angina pectoris patients. Trace Elem Med 1993; 8: 113-7. |
| [147] | Regnstrom J, Nilsson J, Modeus P, Strom K, Bavenhouhu P, Tornvall P Hamsten A. An inverse relation between the concentration of low density lipoproteins vitamin E and severity of coronary artery diseases. AM J. Clin Nurt 1996; 63: 377-85. |
| [148] | Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and the risk of coronary disease in women N. Engl J Med 1993; 328: 1444-9. |
| [149] | Kushi LH, Fee RM, Sellers TA, Zheng W, Folsom AR. Intake of vitamin A, C, and E and postmenopausal breast cancer: the Lowa womens’ Health Study. Am J Epidemiol 1996; 144: 165-74. |
| [150] | Meyer FI, Bairati and GR Dagenais. Lower ischemic heart disease incidence and mortality among vitamin supplement users. Can J Cardiol 1996; 12: 930-4. |
| [151] | Gey, KF, Puska. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann N Y Acad Sci 1989; 570: 268-82. |
| [152] | Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Low plasma vitamins E and C: increased risk of angina in Scottish men. Ann. N. Y. Acad. Sci. 1989; 570: 291-5. |
| [153] | Riemersma RA, Wood DA, McIntyre CAA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991; 337: 1-5 |
| [154] | Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established populations for Epidemiologic studies of the Elderly. Am J. Clin Nurt 1996; 64: 190-6 |
| [155] | Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, Boeing H, Hofman A, Grobbee DE, Witteman JC. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam study. Am J. Clin Nutr 1999; 69: 261-6. |
| [156] | The Gissi-Prevenzione Trial. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI. Lancet 1999; 354: 447-55. |
| [157] | Salonen T, Salonen R, Pentula I, Herranen J, Jauhiainen M, Kantola I et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and risk of death from coronary artery diseases. AM J Cardiol 1985; 56: 226-31 |
| [158] | Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, van Laar A, de Bruin M et al. Serum selenium and vitamin antioxidants and cardiovascular mortality: a 9-year follow-up study in the Netherlands. AM J Clin Nutr 1987: 45; 462-8. |
| [159] | Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trail in Lixian, China: supplementation with specific vitamin/mineral combinations, cancer incipience, and diseases specific mortality in the general population. J Natl Cancer Inst 1993: 85; 1483-91. |
| [160] | Stephens NG, Parsous A, Schofiels PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomized controlled trail of vitamin E and coronary disease: the Cambridge Heart Antioxidant Study (CHAOS). Lancert 1996; 347: 781-6. |
| [161] | The Heart Outcomes Prevention Evaluation Study Investigators (HOPES). Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 154-60. |
| [162] | Pryor WA 2000. Vitamin E and heart diseases: Basic Science to clinical intervention trials. Fre Radic Biol Med 28: 141-64. |
| [163] | Witztum J. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-95. |
| [164] | Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 2002; 105 (17): 2107-11. |
| [165] | Klein H, Pich S, Lindert S, Nebendahl K, Niedmann P, Kreuzer H. Combined treatment with vitamin E and C in experimental Nyocardial infarction in pigs. American Heart Journal. 1989; 188 (4): 667-3. |
| [166] | Freedman JE, Farhat JH, Loscalzo J, Keaney JF. Alpha-tocopherol inhibits aggregation of human platelets by a protein Kinase C-dependent mechanism. Circulation 1996; 94: 2434-40. |
| [167] | Rota S, McWilliam NA, Baglin TP, Byrne CD. Atherosgenic lipoprotein support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E. Blood 1998; 91 (2): 508-15. |
| [168] | Wutzen J, Rozycka Z. Electron microscopic lesions of the myocardium of rats fed a low-magnesium diet. Pol Med Sci Hist Bull 1975: 15 (4): 407-14. |
| [169] | Whang R. Clinical disorders of magnesium metabolism. Compr Ther 1997; 23: 168-73 |
| [170] | Reddy V, Sivakumar B. Magnesium dependent vitamin-D-resistant rickets. Lancet 1974; 1 (7864): 963-65. |
| [171] | Rude RK, Adams JS, Ryzen E, Endres DB, Niimi H, Horst RL, Haddad JG Jr., Singer FR. Low serum concentrations of 1,25-dihydroxy vitamin D in human magnesium deficiency. J Clin Endocrinol Metab 1985; 61 (5): 933-40. |
| [172] | Fuss M, Bergmann P, Bergans A, Bagon J, Cogan E, Pepersack T, Van Gossum M, Corvilain J. Correction of low circulating levels of 1, 25-duhydroxy vitamin D by 25-hydroxy vitamin D during reversal of hypo-magnesaemia. Clin Endocrinol (Oxf) 1989; 31 (1): 31-8. |
| [173] | Rosanoff A, Dai Qi, Shapses SA. Essential nutrient interactions: Does low or suboptimal magnesium interact with vitamin D and/or calcium status? Advan Nutr 2016; 7 (1): 25-43. |
| [174] | Deng X, Song Y, Manson JE, Signorello LB, Zhang SM, Shrubsole MJ, Ness RM, Seidner DL, Dai Q. Magnesium, vitamin D status and mortality: results from US National Helath and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES 111. BMC Med 2013; 11: 187. |
| [175] | Rubin H. Central roles of Mg2+ and Mg ATP2 in the regulation of protein synthesis and cell proliferation: significance for neoplastic transformation. Adv Cancer Res. 2005; 93: 1-58. |
| [176] | Wu F, Altura BT, Gao J, Barbour RL, Altura BM. Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. Biochim Biophys Acta- Mol Basis Dis1994; 1225 (2): 158-64. |
| [177] | Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, α-Tocopherol, and ascorbate. Arch Biochem Biophy 1993; 200 (2): 535-43. |
| [178] | Palozza P, Krinsky NI. Beta-carotene and alpha-tocopherol are synergistic antioxidants. Arch Biochem Biophys 1992; 297: 184-7. |
| [179] | Packer JE, Slater TF, Wilson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979; 737-38. |
| [180] | Leung H-W, Vang MJ, Mavis RD. The co-operative interaction between vitamin E and vitamin C in suppression of peroxidation of membrane phospholipids. Biochem Biophys Acta 1981; 664: 266-72. |
| [181] | Singh RB, Niaz MA, Rastogi SS, Rastogi S. Usefulness of antioxidant vitamins in suspected acute myacardiac infarction (The Indian Experiment of Infarct Survival-3). Am J Cardiol 1996; 77 (2): 232-6. |
| [182] | Witte KK, Clark AI, Cleland JGF. Chronic heart failure and micronutrients. J Am Coll Cardiol 2001; 37 (7): 1765-74. |
| [183] | Miller KB, Caton JS, Schafer DM, Smith DJ, Finley JW. High dietary manganese lowers heart magnesium in pigs fed a low-magnesium diet. J Nutr 2000; 130: 2032-5. |
| [184] | Osredkar J, Susuatr N. Copper and Zinc, biological role and significant of copper/ zinc imbalance. J Clinic Toxicol 2011, S:3 http://dx.doi.org/10.4172/2161-0495.S3-001 |
| [185] | Reunaen A, Knekt P, Marniem J, Makt J, Maatela J, Aromaa A. serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 1996; 50 (7): 431-7. |
APA Style
Christopher Edet Ekpenyong. (2017). Micronutrient Vitamin Deficiencies and Cardiovascular Disease Risk: Advancing Current Understanding. European Journal of Preventive Medicine, 5(1), 1-18. https://doi.org/10.11648/j.ejpm.20170501.11
ACS Style
Christopher Edet Ekpenyong. Micronutrient Vitamin Deficiencies and Cardiovascular Disease Risk: Advancing Current Understanding. Eur. J. Prev. Med. 2017, 5(1), 1-18. doi: 10.11648/j.ejpm.20170501.11
AMA Style
Christopher Edet Ekpenyong. Micronutrient Vitamin Deficiencies and Cardiovascular Disease Risk: Advancing Current Understanding. Eur J Prev Med. 2017;5(1):1-18. doi: 10.11648/j.ejpm.20170501.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ejpm.20170501.11,
author = {Christopher Edet Ekpenyong},
title = {Micronutrient Vitamin Deficiencies and Cardiovascular Disease Risk: Advancing Current Understanding},
journal = {European Journal of Preventive Medicine},
volume = {5},
number = {1},
pages = {1-18},
doi = {10.11648/j.ejpm.20170501.11},
url = {https://doi.org/10.11648/j.ejpm.20170501.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejpm.20170501.11},
abstract = {Cardiovascular diseases are responsible for one-third of all deaths in the world. Several factors contribute to the current trend including micronutrient vitamin deficiencies (MVDs), however, opinions regarding the role of MVDs in CVDs are inconsistent; this could impact on micronutrient vitamins intake. The aim of this review was to provide a brief overview of published evidence on the associations between MVDs and CVDs, assess the interactions between micronutrients and cardiovascular endpoints, and identify current related research needs. Literature search conducted on studies published between 1963 and 2016 indicates that MVDs are common and are related to adverse cardiovascular endpoints through various mechanisms, including impaired antioxidant and immune response mechanisms; and anti-inflammatory activities. Some micronutrients directly impact on CVDs; others act as critical cofactors in several biochemical processes. Several methodologic flaws, environmental and individual susceptibility factors, lack of determination of baseline serum levels of complementary micronutrients, absence of uniformly accepted cut-off values, and interactions between micronutrients may partly account for discordant results across studies. Although MVD is a significant risk factor for CVDs, supplementation with single or paired micronutrients for primary prevention of CVDs in healthy adults with no special nutritional needs is discouraged; there is insufficient evidence to determine the benefit/harm of such supplementation.},
year = {2017}
}
TY - JOUR T1 - Micronutrient Vitamin Deficiencies and Cardiovascular Disease Risk: Advancing Current Understanding AU - Christopher Edet Ekpenyong Y1 - 2017/02/20 PY - 2017 N1 - https://doi.org/10.11648/j.ejpm.20170501.11 DO - 10.11648/j.ejpm.20170501.11 T2 - European Journal of Preventive Medicine JF - European Journal of Preventive Medicine JO - European Journal of Preventive Medicine SP - 1 EP - 18 PB - Science Publishing Group SN - 2330-8230 UR - https://doi.org/10.11648/j.ejpm.20170501.11 AB - Cardiovascular diseases are responsible for one-third of all deaths in the world. Several factors contribute to the current trend including micronutrient vitamin deficiencies (MVDs), however, opinions regarding the role of MVDs in CVDs are inconsistent; this could impact on micronutrient vitamins intake. The aim of this review was to provide a brief overview of published evidence on the associations between MVDs and CVDs, assess the interactions between micronutrients and cardiovascular endpoints, and identify current related research needs. Literature search conducted on studies published between 1963 and 2016 indicates that MVDs are common and are related to adverse cardiovascular endpoints through various mechanisms, including impaired antioxidant and immune response mechanisms; and anti-inflammatory activities. Some micronutrients directly impact on CVDs; others act as critical cofactors in several biochemical processes. Several methodologic flaws, environmental and individual susceptibility factors, lack of determination of baseline serum levels of complementary micronutrients, absence of uniformly accepted cut-off values, and interactions between micronutrients may partly account for discordant results across studies. Although MVD is a significant risk factor for CVDs, supplementation with single or paired micronutrients for primary prevention of CVDs in healthy adults with no special nutritional needs is discouraged; there is insufficient evidence to determine the benefit/harm of such supplementation. VL - 5 IS - 1 ER -
Information
Email: